United States - English - NLM (National Library of Medicine)

chartwell rx, llc - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. influenza a prophylaxis amantadine hydrochloride capsules are indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. influenza a treatment amantadine hydrochloride capsules are also indicated in the treatment of uncomplicated respiratory tract illnes

United States - English - NLM (National Library of Medicine)

edenbridge pharmaceuticals llc. - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride tablets are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. influenza a prophylaxis amantadine hydrochloride tablets are indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine hydrochloride tablets do not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine hydrochloride tablets prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. influenza a treatment amantadine hydrochloride tablets are also indicated in the treatment of u

Malta - English - Medicines Authority

morningside healthcare limited unit c, harcourt way, leicester, le19 1wp, united kingdom - amantadine hydrochloride - hard capsule - amantadine hydrochloride 100 mg - anti-parkinson drugs

Malta - English - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - amantadine hydrochloride - hard capsule - amantadine hydrochloride 100 mg - anti-parkinson drugs

Ireland - English - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - amantadine hydrochloride - capsule, hard - amantadine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - amantadine hydrochloride - oral capsule - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - amantadine hydrochloride - oral solution - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

northumbria pharma ltd - amantadine hydrochloride - oral solution - 10mg/1ml

Canada - English - Health Canada

dominion pharmacal - amantadine hydrochloride - capsule - 100mg - amantadine hydrochloride 100mg - adamantanes

United States - English - NLM (National Library of Medicine)

unit dose services - amantadine hydrochloride (unii: m6q1eo9td0) (amantadine - unii:bf4c9z1j53) - amantadine hydrochloride oral solution usp is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza a virus. amantadine hydrochloride is also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. amantadine hydrochloride is indicated for chemoprophylaxis against signs and symptoms of influenza a virus infection. because amantadine hydrochloride does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. following vaccination during an influenza a outbreak, amantadine hydrochloride prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. amantadine hydrochloride is also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza a virus strains es